Hans Georg Rammensee

Hans Georg Rammensee

Universität Tubingen - Tübingen / Germany
Medical and Health Sciences / Immunology
AD Scientific Index ID: 1787509
Eberhard Karls University of Tübingen
person_outline Hans Georg Rammensee's MOST POPULAR ARTICLES
1-) Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens Nature 515 (7528), 577-581, 2014
2-) MHC ligands and peptide motifs: first listing Immunogenetics 41, 178-228, 1995
3-) Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival Nature medicine 18 (8), 1254-1261, 2012
4-) MHC ligands and peptide motifs: first listingHG Rammensee, T Friede, S StevanovićImmunogenetics 41, 178-228, 199521881995
5-) Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survivalS Walter, T Weinschenk, A Stenzl, R Zdrojowy, A Pluzanska, C Szczylik, ...Nature medicine 18 (8), 1254-1261, 201216402012